vs

Side-by-side financial comparison of electroCore, Inc. (ECOR) and Marygold Companies, Inc. (MGLD). Click either name above to swap in a different company.

electroCore, Inc. is the larger business by last-quarter revenue ($9.2M vs $7.6M, roughly 1.2× Marygold Companies, Inc.). Marygold Companies, Inc. runs the higher net margin — -7.5% vs -32.8%, a 25.3% gap on every dollar of revenue. On growth, electroCore, Inc. posted the faster year-over-year revenue change (31.2% vs -4.5%). Over the past eight quarters, electroCore, Inc.'s revenue compounded faster (30.3% CAGR vs -1.5%).

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.

ECOR vs MGLD — Head-to-Head

Bigger by revenue
ECOR
ECOR
1.2× larger
ECOR
$9.2M
$7.6M
MGLD
Growing faster (revenue YoY)
ECOR
ECOR
+35.7% gap
ECOR
31.2%
-4.5%
MGLD
Higher net margin
MGLD
MGLD
25.3% more per $
MGLD
-7.5%
-32.8%
ECOR
Faster 2-yr revenue CAGR
ECOR
ECOR
Annualised
ECOR
30.3%
-1.5%
MGLD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ECOR
ECOR
MGLD
MGLD
Revenue
$9.2M
$7.6M
Net Profit
$-3.0M
$-576.0K
Gross Margin
88.4%
74.0%
Operating Margin
-31.8%
-8.3%
Net Margin
-32.8%
-7.5%
Revenue YoY
31.2%
-4.5%
Net Profit YoY
6.0%
67.0%
EPS (diluted)
$-0.34
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECOR
ECOR
MGLD
MGLD
Q4 25
$9.2M
$7.6M
Q3 25
$8.7M
$7.0M
Q2 25
$7.4M
$7.2M
Q1 25
$6.7M
$7.0M
Q4 24
$7.0M
$8.0M
Q3 24
$6.6M
$7.9M
Q2 24
$6.1M
$8.3M
Q1 24
$5.4M
$7.9M
Net Profit
ECOR
ECOR
MGLD
MGLD
Q4 25
$-3.0M
$-576.0K
Q3 25
$-3.4M
$-356.0K
Q2 25
$-3.7M
$-1.5M
Q1 25
$-3.9M
$-1.0M
Q4 24
$-3.2M
$-1.7M
Q3 24
$-2.5M
$-1.6M
Q2 24
$-2.7M
$-1.9M
Q1 24
$-3.5M
$-529.0K
Gross Margin
ECOR
ECOR
MGLD
MGLD
Q4 25
88.4%
74.0%
Q3 25
86.0%
77.0%
Q2 25
87.3%
67.8%
Q1 25
84.9%
75.0%
Q4 24
85.9%
74.1%
Q3 24
83.8%
73.1%
Q2 24
86.3%
72.5%
Q1 24
83.7%
70.5%
Operating Margin
ECOR
ECOR
MGLD
MGLD
Q4 25
-31.8%
-8.3%
Q3 25
-33.2%
-18.2%
Q2 25
-47.5%
-16.5%
Q1 25
-56.9%
-21.4%
Q4 24
-43.6%
-22.8%
Q3 24
-40.4%
-27.4%
Q2 24
-42.2%
-33.3%
Q1 24
-70.7%
-18.7%
Net Margin
ECOR
ECOR
MGLD
MGLD
Q4 25
-32.8%
-7.5%
Q3 25
-39.2%
-5.1%
Q2 25
-49.7%
-20.4%
Q1 25
-57.4%
-14.4%
Q4 24
-45.8%
-21.8%
Q3 24
-38.1%
-20.1%
Q2 24
-43.2%
-22.5%
Q1 24
-64.4%
-6.7%
EPS (diluted)
ECOR
ECOR
MGLD
MGLD
Q4 25
$-0.34
$-0.01
Q3 25
$-0.40
$-0.01
Q2 25
$-0.44
$-0.04
Q1 25
$-0.47
$-0.02
Q4 24
$-0.37
$-0.04
Q3 24
$-0.31
$-0.04
Q2 24
$-0.38
$-0.05
Q1 24
$-0.53
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECOR
ECOR
MGLD
MGLD
Cash + ST InvestmentsLiquidity on hand
$11.6M
$11.6M
Total DebtLower is stronger
$7.8M
Stockholders' EquityBook value
$-1.7M
$22.7M
Total Assets
$18.7M
$27.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECOR
ECOR
MGLD
MGLD
Q4 25
$11.6M
$11.6M
Q3 25
$13.0M
$12.5M
Q2 25
$7.1M
$12.8M
Q1 25
$7.8M
$15.6M
Q4 24
$12.2M
$14.9M
Q3 24
$12.9M
$17.5M
Q2 24
$14.2M
$15.0M
Q1 24
$7.8M
$16.1M
Total Debt
ECOR
ECOR
MGLD
MGLD
Q4 25
$7.8M
Q3 25
$7.8M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECOR
ECOR
MGLD
MGLD
Q4 25
$-1.7M
$22.7M
Q3 25
$-1.1M
$22.9M
Q2 25
$1.1M
$23.0M
Q1 25
$4.4M
$24.3M
Q4 24
$7.5M
$23.4M
Q3 24
$9.5M
$25.5M
Q2 24
$11.5M
$26.6M
Q1 24
$4.5M
$28.4M
Total Assets
ECOR
ECOR
MGLD
MGLD
Q4 25
$18.7M
$27.8M
Q3 25
$21.4M
$28.4M
Q2 25
$14.6M
$30.4M
Q1 25
$16.0M
$33.5M
Q4 24
$20.5M
$33.0M
Q3 24
$21.0M
$35.9M
Q2 24
$22.4M
$32.9M
Q1 24
$13.9M
$33.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECOR
ECOR
MGLD
MGLD
Operating Cash FlowLast quarter
$-1.5M
$-908.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECOR
ECOR
MGLD
MGLD
Q4 25
$-1.5M
$-908.0K
Q3 25
$-1.7M
$-533.0K
Q2 25
$-623.0K
$-3.3M
Q1 25
$-4.4M
$-1.2M
Q4 24
$-1.3M
$-770.0K
Q3 24
$-1.4M
$-893.0K
Q2 24
$-1.8M
$-1.9M
Q1 24
$-2.6M
$-658.0K
Free Cash Flow
ECOR
ECOR
MGLD
MGLD
Q4 25
Q3 25
$-1.7M
$-562.0K
Q2 25
$-648.0K
$-3.4M
Q1 25
$-4.4M
Q4 24
$-776.0K
Q3 24
$-940.0K
Q2 24
$-2.0M
Q1 24
FCF Margin
ECOR
ECOR
MGLD
MGLD
Q4 25
Q3 25
-19.3%
-8.1%
Q2 25
-8.8%
-46.8%
Q1 25
-65.4%
Q4 24
-9.7%
Q3 24
-11.9%
Q2 24
-23.8%
Q1 24
Capex Intensity
ECOR
ECOR
MGLD
MGLD
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.4%
Q2 25
0.3%
0.7%
Q1 25
0.6%
0.0%
Q4 24
0.1%
Q3 24
0.6%
Q2 24
0.7%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECOR
ECOR

Segment breakdown not available.

MGLD
MGLD

Fund Management Related Party$4.6M60%
Food Products$1.7M22%
Beauty Products$1.2M15%
Other$268.0K4%

Related Comparisons